| Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial O Klein, D Kee, B Gao, B Markman, J da Gama Duarte, L Quigley, ... Journal for Immunotherapy of Cancer 9 (11), 2021 | 7 | 2021 |
| Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal™-TSA multiplex immunohistochemistry LT Quigley, L Pang, E Tavancheh, M Ernst, A Behren, J Huynh, ... STAR protocols 4 (1), 101961, 2023 | 6 | 2023 |
| Ropporin-1 and 1b are widely expressed in human melanoma and evoke strong humoral immune responses J Da Gama Duarte, K Woods, LT Quigley, C Deceneux, C Tutuka, ... Cancers 13 (8), 1805, 2021 | 4 | 2021 |
| Identification of tumor antigens in ovarian cancers using local and circulating tumor-specific antibodies J Da Gama Duarte, LT Quigley, AR Young, M Hayashi, M Miyazawa, ... International journal of molecular sciences 22 (20), 11220, 2021 | 3 | 2021 |
| B Cells and Antibody Production in Cancer J Da Gama Duarte, E Tavancheh, LT Quigley, S Ostrouska, A Behren Handbook of Cancer and Immunology, 1-20, 2023 | | 2023 |
| Combination immunotherapy in patients with rare cancers. A Behren, A Gunjur, D Kee, B Markman, M Michael, C Underhill, ... EUROPEAN JOURNAL OF IMMUNOLOGY 53, 153-153, 2023 | | 2023 |
| A multispectral immunohistochemistry panel to investigate T cells and butyrophilin molecules in the tumour microenvironment JDG Duarte, LT Quigley, E Tavancheh, S Ostrouska, A Behren Exploration of Immunology 2 (3), 383-392, 2022 | | 2022 |
| Ipilimumab and nivolumab in patients with rare gynaecological malignancies: Results of an Australian, multi-centre, phase 2 trial (CA209-538) D Kee, O Klein, B Gao, B Markman, J Da Gama Duarte, L Quigley, ... | | 2021 |
| Novel Diagnostic and Prognostic Biomarkers in Prostate Cancer L Quigley La Trobe, 2020 | | 2020 |
